Together we will beat cancer

Donate

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

Read More

Leukaemia drug gets initial ‘no’ for NHS in England

Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England.

Read More

Double NHS decision for CAR T cell immunotherapy in Scotland

Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.

Read More

First patient receives CAR T cell therapy on NHS

An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS.

Read More

Chelsea legend Gianfranco Zola surprises Blues fan and cancer survivor

Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto

Read More

NHS England to fund personalised blood cancer immunotherapy

A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today.

Read More

Doubling-up on cancer immunotherapy shows promise, but side effects still a challenge

A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer.

Read More

Scientists identify possible double whammy to attack leukaemia

Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia.

Read More

Cancer Research UK launches trial of new drug to treat acute childhood leukaemia

Cancer Research UK’s Drug Development Office has opened the first trial of a new type of leukaemia drug.

Read More

Trial results show dramatically improved survival for relapsed childhood leukaemia

A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.

Read More